These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36873173)
1. Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia. Xie Z; Zhang M; Song Q; Cheng L; Zhang X; Song G; Sun X; Gu M; Zhou C; Zhang Y; Zhu K; Yin J; Chen X; Li J; Nan F Acta Pharm Sin B; 2023 Feb; 13(2):739-753. PubMed ID: 36873173 [TBL] [Abstract][Full Text] [Related]
2. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis. Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055 [TBL] [Abstract][Full Text] [Related]
3. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review. Feng X; Zhang L; Xu S; Shen AZ Prog Lipid Res; 2020 Jan; 77():101006. PubMed ID: 31499095 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice. Hallows KR; Li H; Saitta B; Sepehr S; Huang P; Pham J; Wang J; Mancino V; Chung EJ; Pinkosky SL; Pastor-Soler NM Front Mol Biosci; 2022; 9():1001941. PubMed ID: 36504724 [TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. Dufort FJ; Gumina MR; Ta NL; Tao Y; Heyse SA; Scott DA; Richardson AD; Seyfried TN; Chiles TC J Biol Chem; 2014 Mar; 289(10):7011-7024. PubMed ID: 24469453 [TBL] [Abstract][Full Text] [Related]
7. ATP Citrate Lyase Supports Cardiac Function and NAD+/NADH Balance And Is Depressed in Human Heart Failure. Meddeb M; Koleini N; Jun S; Keykhaei M; Farshidfar F; Zhao L; Kwon S; Lin B; Keceli G; Paolocci N; Hahn V; Sharma K; Pearce EL; Kass DA bioRxiv; 2024 Jun; ():. PubMed ID: 38915649 [TBL] [Abstract][Full Text] [Related]
8. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis. Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087 [TBL] [Abstract][Full Text] [Related]
9. Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPKα signaling pathway. Liu W; Liu M; Xiong H; Xia L; Yang Q; Chen M; Cai Y; Li S Int Immunopharmacol; 2022 Dec; 113(Pt A):109392. PubMed ID: 36461594 [TBL] [Abstract][Full Text] [Related]
10. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Migita T; Narita T; Nomura K; Miyagi E; Inazuka F; Matsuura M; Ushijima M; Mashima T; Seimiya H; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y Cancer Res; 2008 Oct; 68(20):8547-54. PubMed ID: 18922930 [TBL] [Abstract][Full Text] [Related]
11. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms. Zaidi N; Royaux I; Swinnen JV; Smans K Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913 [TBL] [Abstract][Full Text] [Related]
14. Bempedoic acid: effect of ATP-citrate lyase inhibition on low-density lipoprotein cholesterol and other lipids. Paton DM Drugs Today (Barc); 2020 Sep; 56(9):573-582. PubMed ID: 33025951 [TBL] [Abstract][Full Text] [Related]
15. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis. Verberk SGS; Kuiper KL; Lauterbach MA; Latz E; Van den Bossche J Trends Mol Med; 2021 Dec; 27(12):1095-1105. PubMed ID: 34635427 [TBL] [Abstract][Full Text] [Related]
16. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells. Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799 [TBL] [Abstract][Full Text] [Related]
17. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway. Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309 [TBL] [Abstract][Full Text] [Related]
18. ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score. Sanjay KV; Vishwakarma S; Zope BR; Mane VS; Mohire S; Dhakshinamoorthy S Curr Res Pharmacol Drug Discov; 2021; 2():100051. PubMed ID: 34909677 [TBL] [Abstract][Full Text] [Related]
19. ATP citrate lyase: A central metabolic enzyme in cancer. Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561 [TBL] [Abstract][Full Text] [Related]
20. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury. Li R; Meng M; Chen Y; Pan T; Li Y; Deng Y; Zhang R; Tian R; Xu W; Zheng X; Gong F; Liu J; Tang H; Ding X; Tang Y; Annane D; Chen E; Qu H; Li L Cell Death Dis; 2023 Jul; 14(7):401. PubMed ID: 37414769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]